Disease-modifying anti-rheumatic drugs
Bachmeier, Clarissa, Brooks, Peter M., Day, Richard O., Graham, Garry G., Littlejohn, Geoffrey O., Morand, Eric F., Pile, Kevin, and Williams, Kenneth M. (2005) Disease-modifying anti-rheumatic drugs. In: Nijkamp, Frans P., and Parnham, Michael J., (eds.) Principles of Immunopharmacology. Birkhäuser Basel, pp. 511-544.
| 
 | Image (JPEG) (Book Cover)
 - Cover Image Download (59kB) | |
| ![[img]](https://researchonline.jcu.edu.au/style/images/fileicons/application_pdf.png) | PDF (Published Version)
 - Published Version Restricted to Repository staff only | 
Abstract
[Extract] Rheumatoid arthritis is the most common inflammatory rheumatic disease, and has a prevalence of about 1% [1]. The total incidence of this disease is low but its burden is significant. Untreated, rheumatoid arthritis usually leads to join destruction, disability and increased mortality. Long-term management of patients is required, based not only on drug treatment, but also on non-pharmacological approaches such as physiotherapy and psychosocial support.
| Item ID: | 26656 | 
|---|---|
| Item Type: | Book Chapter (Non-Research) | 
| ISBN: | 978-3-7643-5804-4 | 
| Keywords: | anti-rheumatic drugs, pathophysiology | 
| Date Deposited: | 24 Apr 2013 06:24 | 
| FoR Codes: | 11 MEDICAL AND HEALTH SCIENCES > 1103 Clinical Sciences > 110322 Rheumatology and Arthritis @ 100% | 
| SEO Codes: | 92 HEALTH > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920116 Skeletal System and Disorders (incl. Arthritis) @ 100% | 
| Downloads: | Total: 355 Last 12 Months: 28 | 
| More Statistics | 
 
                        	